Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bath PMW et al. – Treatment with telmisartan in 1360 patients with acute mild ischemic stroke and mildly elevated BP appeared to be safe with no excess in adverse events, was not associated with a significant effect on functional dependency, death, or recurrence, and modestly lowered BP.

Exclusive Author Commentary
Philip M. W. Bath, 09/28/09

The data suggest that moderate lowering of BP is at least safe in patients with recent mild ischaemic stroke. But it will take larger ongoing trials (e.g. ENOS, SCAST) to define effects on efficacy. ENOS: http://www.enos.ac.uk/ SCAST: http://www.scast.no/


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address